Vor Biopharma (VOR) Enterprise Value (2020 - 2026)
Vor Biopharma (VOR) reported Enterprise Value of -$491.5 million for Q1 2026, down 718.73% year-over-year from $79.4 million in Q1 2025, and down 7.98% quarter-over-quarter from -$455.2 million in Q4 2025.
Vor Biopharma (VOR) Enterprise Value (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has 7 years of Enterprise Value data on file, last reported at -$491.5 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$491.5 million, down 718.73% year-over-year; the trailing twelve-month figure through Mar 2026 was -$491.5 million (down 718.73% YoY), and the FY2025 annual result was -$455.2 million, down 395.19% from the prior year.
- Enterprise Value eased to -$491.5 million in Q1 2026 per VOR's latest filing, from -$455.2 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$60.0 million in Q1 2025 and troughed at -$491.5 million in Q1 2026.
- A 5-year average of -$183.5 million and a median of -$160.1 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2026: Enterprise Value soared 60.77% in 2024, then tumbled 718.73% in 2026.
- A 5-year view of Enterprise Value shows it stood at -$230.2 million in 2022, then jumped by 40.42% to -$137.2 million in 2023, then jumped by 32.99% to -$91.9 million in 2024, then plunged by 395.19% to -$455.2 million in 2025, then slipped by 7.98% to -$491.5 million in 2026.
- Business Quant data shows VOR's Enterprise Value at -$491.5 million in Q1 2026, -$455.2 million in Q4 2025, and -$170.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Vor Biopharma | 627.54 Mn | 627.54 Mn | - | -491.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -491.53 Mn |
| Dec 31, 2025 | -455.21 Mn |
| Sep 30, 2025 | -170.46 Mn |
| Jun 30, 2025 | -200.57 Mn |
| Mar 31, 2025 | -60.04 Mn |
| Dec 31, 2024 | -91.93 Mn |
| Sep 30, 2024 | -62.81 Mn |
| Jun 30, 2024 | -85.94 Mn |
| Mar 31, 2024 | -107.48 Mn |
| Dec 31, 2023 | -137.18 Mn |
| Sep 30, 2023 | -160.10 Mn |
| Jun 30, 2023 | -186.90 Mn |
| Mar 31, 2023 | -210.20 Mn |
| Dec 31, 2022 | -230.25 Mn |
| Sep 30, 2022 | -136.07 Mn |
| Jun 30, 2022 | -151.09 Mn |
| Mar 31, 2022 | -181.62 Mn |
| Dec 31, 2021 | -207.47 Mn |
| Sep 30, 2021 | -225.97 Mn |
| Jun 30, 2021 | -244.63 Mn |